Patent Law

Navigating the balance between protecting innovation and ensuring access to affordable medications is crucial. Join our speakers in this CLE webcast as they delve into the intricacies of the Hatch-Waxman Act and its profound impact on the pharmaceutical industry. Designed for legal professionals, pharmaceutical executives, and anyone navigating the complex landscape of drug development, this webinar will provide invaluable insights into leveraging Hatch-Waxman strategies to safeguard intellectual property while ensuring broader access to life-saving medications.

Navigating the ever-changing world of patent damages may leave you feeling lost. Join Christopher Johanson and Rebekah C. Bezerra of FTI Consulting in this CLE webcast where they equip you with the knowledge and tools to navigate the complex and evolving landscape of patent litigation. Discover key insights and best practices to maximize your chances of success, whether you’re a patent owner, infringer, or attorney.

In the ever-changing field of artificial intelligence (AI), innovation serves as the foundation for progress. The act of patenting AI inventions goes beyond a mere legal procedure; it is a strategic step that safeguards your intellectual property, opens doors to commercial success, and advances technology. However, the journey to patent AI technology is far from straightforward, with a landscape filled with nuances, complexities, and unique challenges.

In February 2022, the United States Court of Appeals for the Federal Circuit (CAFC) revoked the decisions on Apple Inc. v. Wi-LAN Inc. and California Inst. of Tech. v. Broadcom Ltd. due to flawed expert’s opinion. This resulted in the vacation of previous verdicts of $85 million and $1.1 billion and the remand of new trials on damages. This notable development underscores the significance of an expert’s opinion to be tethered to the facts of the case to ensure its admissibility.